BDX Stock Summary and Trading Ideas (Becton Dickinson And Company | NYSE:BDX)

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.

As of April 22, 2024, BDX stock price declined to $233.88 with 681,926 million shares trading.

BDX has a beta of 0.67, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.15 to the broad based SPY ETF.

BDX has a market cap of $67.72 billion. This is considered a Large Cap stock.

Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $2.68 earnings per share. This fell short of revenue expectation by $-24 million and exceeded earnings estimates by $.28.

In the last 3 years, BDX stock traded as high as $287.32 and as low as $215.90.

The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.

BDX has underperformed the market in the last year with a return of -9.0%, while the SPY ETF gained +22.9%. In the last 3 month period, BDX fell short of the market, returning -0.4%, while SPY returned +3.7%. However, in the most recent 2 weeks BDX has outperformed the stock market by returning -3.2%, while SPY returned -3.7%.

BDX support price is $231.30 and resistance is $236.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX stock will trade within this expected range on the day.